Peter Gottlieb is an Endocrinology/Metabolic physician. ClinicalTrials.gov lists 3 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Research metrics aren't shown for this record. Either we found no confident publication match for this name, or more than one physician shares the matched author record. We'd rather show nothing than someone else's numbers. Why? →
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
12605 E 16th Ave
Aurora, CO 800452545
Telephone
303-493-7000Registry record last updated 13 Nov 2014.
Clinical trials
- MER3101: MAS-1 Adjuvanted Antigen-specific Immunotherapeutic for Prevention and Treatment of Type 1 Diabetes
Sponsor: University of Colorado, Denver
- The Effects of Alpha-1 Antitrypsin (AAT) on the Progression of Type 1 Diabetes
Sponsor: University of Colorado, Denver
- Phase 1 Study of BHT-3021 in Subjects With Type 1 Diabetes Mellitus
Sponsor: Bayhill Therapeutics
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
6 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- GENZYME CORPORATIONProgram year20255 payments$18,479openpaymentsdata.cms.gov ↗
- Eli Lilly and CompanyProgram year20251 payment
- Novo Nordisk ASProgram year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
47.4%Insulin Analog27.8%Humalog35%Lantus Solostar14%Humalog Kwikpen U-10013%Lantus12%Novolog7%Insulin Lispro7%Lyumjev6%Novolog Flexpen6%Part D<11 patientsGLP-1 receptor agonist8.5%Ozempic58%Trulicity24%Mounjaro18%Part D<11 patients+ 4 more classes in this area
Cardiovascular
31.6%Statin14.3%Atorvastatin Calcium51%Rosuvastatin Calcium34%Pravastatin Sodium15%Part D<11 patientsAngiotensin receptor blocker (ARB)6.6%Losartan Potassium100%Part D≥13 patients+ 3 more classes in this area
Hormonal (systemic)
13.2%l-Thyroxine11.7%Levothyroxine Sodium85%Synthroid15%Part D<11 patientsThyroid hormones1.5%Np Thyroid100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
6 NIH research awards on record, funded 2000–2018 per NIH RePORTER. The latest:
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Similar KOLs
Other experts from the same institution or the same specialty.
Bruce Bartholow Duncan
Universidade Federal do Rio Grande do Sul
Alireza Esteghamati
Tehran University of Medical Sciences
Paul Zimmet
Monash University
André Pascal Kengne
South African Medical Research Council
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”